Pellficure Pharmaceuticals, Inc.
Records under this name other than the patents Pellficure Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Pellficure Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,093,620 | Compositions and Methods for Treatment of Prostate Carcinoma Lapsed on the fee record Ended Oct 9, 2026 · High confidence | Lapsed on the fee record | Ended Oct 9, 2026 | High confidence |
| US 9,877,932 | Treatment of prostate carcinoma Lapsed on the fee record Ended Jan 30, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2026 | From the USPTO record |
| US 9,655,868 | Treatment of prostate carcinoma Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |